Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patients
2017-01-01 Resteghini, C.; Cavalieri, S.; Galbiati, D.; Granata, R.; Alfieri, S.; Bergamini, C.; Bossi, P.; Licitra, L.; Locati, L. D.
The Case Volume Issue in Head and Neck Oncology
2017-01-01 Alfieri, S.; Orlandi, E.; Bossi, P.
The use of intensive radiological assessments in routine surveillance after treatment for head and neck cancer: An economic evaluation
2018-01-01 Meregaglia, M.; Cairns, J.; Licitra, L.; Bossi, P.
Managing older patients with head and neck cancer: The non-surgical curative approach
2018-01-01 Iqbal, M. S.; Dua, D.; Kelly, C.; Bossi, P.
Immuno-oncology in head and neck squamous cell cancers: News from clinical trials, emerging predictive factors and unmet needs
2018-01-01 Cavalieri, S.; Rivoltini, L.; Bergamini, C.; Locati, L. D.; Licitra, L.; Bossi, P.
Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies?
2017-01-01 Bossi, P.; Siano, M.; Bergamini, C.; Cossu Rocca, M.; Sponghini, A. P.; Giannoccaro, M.; Tonella, L.; Paoli, A.; Marchesi, E.; Perrone, F.; Pilotti, S.; Locati, L. D.; Canevari, S.; Licitra, L.; De Cecco, L.
Retreatment with Vismodegib after Progression in Advanced Basal Cell Carcinoma: First-Time Report of a Single-Institution Experience
2018-01-01 Alfieri, S.; Bergamini, C.; Granata, R.; Locati, L.; Licitra, L.; Bossi, P.
Is restoring platinum sensitivity the best goal for cetuximab in recurrent/metastatic nasopharyngeal cancer? [15]
2005-01-01 Licitra, L.; Bossi, P.; Locati, L. D.; Bergamini, C.
Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma
2006-01-01 Perrone, F.; Suardi, S.; Pastore, E.; Casieri, P.; Orsenigo, M.; Caramuta, S.; Dagrada, G.; Losa, M.; Licitra, L.; Bossi, P.; Staurengo, S.; Oggionni, M.; Locati, L.; Cantu, G.; Squadrelli, M.; Carbone, A.; Pierotti, M. A.; Pilotti, S.
An environment for guideline-based decision support systems for outpatients monitoring
2017-01-01 Zini, E. M.; Lanzola, G.; Bossi, P.; Quaglini, S.
A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin
2017-01-01 Bossi, P.; Cortinovis, D.; Fatigoni, S.; Cossu Rocca, M.; Fabi, A.; Seminara, P.; Ripamonti, C.; Alfieri, S.; Granata, R.; Bergamini, C.; Agustoni, F.; Bidoli, P.; Nole, F.; Pessi, M. A.; Macchi, F.; Michellini, L.; Montanaro, F.; Roila, F.
Regionally advanced nasopharyngeal carcinoma: Long-term outcome after sequential chemotherapy and radiotherapy
2004-01-01 Palazzi, M.; Guzzo, M.; Bossi, P.; Tomatis, S.; Cerrotta, A.; Cantu, G.; Locati, L. D.; Licitra, L.
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
2017-01-01 Bossi, P.; Miceli, R.; Locati, L. D.; Ferrari, D.; Vecchio, S.; Moretti, G.; Denaro, N.; Caponigro, F.; Airoldi, M.; Moro, C.; Vaccher, E.; Sponghini, A.; Caldara, A.; Rinaldi, G.; Ferrau, F.; Nole, F.; Lo Vullo, S.; Tettamanzi, F.; Hollander, L.; Licitra, L.
Timing of chemoradiotherapy and patient selection for locally advanced nasopharyngeal carcinoma
2003-01-01 Sanguineti, G.; Bossi, P.; Pou, A.; Licitra, L.
Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN)
2018-01-01 Machiels, J. -P.; Bossi, P.; Menis, J.; Lia, M.; Fortpied, C.; Liu, Y.; Lhommel, R.; Lemort, M.; Schmitz, S.; Canevari, S.; De Cecco, L.; Guzzo, M.; Bianchi, R.; Quattrone, P.; Crippa, F.; Duprez, T.; Lalami, Y.; Quiriny, M.; de Saint Aubain, N.; Clement, P. M.; Coropciuc, R.; Hauben, E.; Licitra, L. F.
Is PSA useful in the diagnosis and monitoring of parotid adenocarcinomas?
2005-01-01 Bergamini, C.; Barisella, M.; Locati, L. D.; Bossi, P.; Potepan, P.; Rinaldi, G.; Licitra, L.
Lung metastasectomy in adenoid cystic carcinoma (ACC) of salivary gland
2005-01-01 Locati, L. D.; Guzzo, M.; Bossi, P.; Massone, P. P. B.; Conti, B.; Fumagalli, E.; Bareggi, C.; Cantu, G.; Licitra, L.
A complete remission with androgen-deprivation therapy in a recurrent androgen recptor-expressing adenocarcinoma of the parotid gland [1]
2003-01-01 Locati, L. D.; Quattrone, P.; Bossi, P.; Marchiano, A. V.; Cantu, G.; Licitra, L.
Head and neck tumors other than squamous cell carcinoma
2004-01-01 Licitra, L.; Locati, L. D.; Bossi, P.; Cantu, G.
Circulating pre-treatment Epstein-Barr virus DNA as prognostic factor in locally-advanced nasopharyngeal cancer in a nonendemic area
2017-01-01 Alfieri, S.; Iacovelli, N. A.; Marceglia, S.; Lasorsa, I.; Resteghini, C.; Taverna, F.; Mazzocchi, A.; Orlandi, E.; Guzzo, M.; Bianchi, R.; Fanti, D.; Pala, L.; Racca, S.; Dvir, R.; Quattrone, P.; Gloghini, A.; Volpi, C. C.; Granata, R.; Bergamini, C.; Locati, L.; Licitra, L.; Bossi, P.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patients | 1-gen-2017 | Resteghini, C.; Cavalieri, S.; Galbiati, D.; Granata, R.; Alfieri, S.; Bergamini, C.; Bossi, P.; Licitra, L.; Locati, L. D. | |
| The Case Volume Issue in Head and Neck Oncology | 1-gen-2017 | Alfieri, S.; Orlandi, E.; Bossi, P. | |
| The use of intensive radiological assessments in routine surveillance after treatment for head and neck cancer: An economic evaluation | 1-gen-2018 | Meregaglia, M.; Cairns, J.; Licitra, L.; Bossi, P. | |
| Managing older patients with head and neck cancer: The non-surgical curative approach | 1-gen-2018 | Iqbal, M. S.; Dua, D.; Kelly, C.; Bossi, P. | |
| Immuno-oncology in head and neck squamous cell cancers: News from clinical trials, emerging predictive factors and unmet needs | 1-gen-2018 | Cavalieri, S.; Rivoltini, L.; Bergamini, C.; Locati, L. D.; Licitra, L.; Bossi, P. | |
| Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies? | 1-gen-2017 | Bossi, P.; Siano, M.; Bergamini, C.; Cossu Rocca, M.; Sponghini, A. P.; Giannoccaro, M.; Tonella, L.; Paoli, A.; Marchesi, E.; Perrone, F.; Pilotti, S.; Locati, L. D.; Canevari, S.; Licitra, L.; De Cecco, L. | |
| Retreatment with Vismodegib after Progression in Advanced Basal Cell Carcinoma: First-Time Report of a Single-Institution Experience | 1-gen-2018 | Alfieri, S.; Bergamini, C.; Granata, R.; Locati, L.; Licitra, L.; Bossi, P. | |
| Is restoring platinum sensitivity the best goal for cetuximab in recurrent/metastatic nasopharyngeal cancer? [15] | 1-gen-2005 | Licitra, L.; Bossi, P.; Locati, L. D.; Bergamini, C. | |
| Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma | 1-gen-2006 | Perrone, F.; Suardi, S.; Pastore, E.; Casieri, P.; Orsenigo, M.; Caramuta, S.; Dagrada, G.; Losa, M.; Licitra, L.; Bossi, P.; Staurengo, S.; Oggionni, M.; Locati, L.; Cantu, G.; Squadrelli, M.; Carbone, A.; Pierotti, M. A.; Pilotti, S. | |
| An environment for guideline-based decision support systems for outpatients monitoring | 1-gen-2017 | Zini, E. M.; Lanzola, G.; Bossi, P.; Quaglini, S. | |
| A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin | 1-gen-2017 | Bossi, P.; Cortinovis, D.; Fatigoni, S.; Cossu Rocca, M.; Fabi, A.; Seminara, P.; Ripamonti, C.; Alfieri, S.; Granata, R.; Bergamini, C.; Agustoni, F.; Bidoli, P.; Nole, F.; Pessi, M. A.; Macchi, F.; Michellini, L.; Montanaro, F.; Roila, F. | |
| Regionally advanced nasopharyngeal carcinoma: Long-term outcome after sequential chemotherapy and radiotherapy | 1-gen-2004 | Palazzi, M.; Guzzo, M.; Bossi, P.; Tomatis, S.; Cerrotta, A.; Cantu, G.; Locati, L. D.; Licitra, L. | |
| A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck | 1-gen-2017 | Bossi, P.; Miceli, R.; Locati, L. D.; Ferrari, D.; Vecchio, S.; Moretti, G.; Denaro, N.; Caponigro, F.; Airoldi, M.; Moro, C.; Vaccher, E.; Sponghini, A.; Caldara, A.; Rinaldi, G.; Ferrau, F.; Nole, F.; Lo Vullo, S.; Tettamanzi, F.; Hollander, L.; Licitra, L. | |
| Timing of chemoradiotherapy and patient selection for locally advanced nasopharyngeal carcinoma | 1-gen-2003 | Sanguineti, G.; Bossi, P.; Pou, A.; Licitra, L. | |
| Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN) | 1-gen-2018 | Machiels, J. -P.; Bossi, P.; Menis, J.; Lia, M.; Fortpied, C.; Liu, Y.; Lhommel, R.; Lemort, M.; Schmitz, S.; Canevari, S.; De Cecco, L.; Guzzo, M.; Bianchi, R.; Quattrone, P.; Crippa, F.; Duprez, T.; Lalami, Y.; Quiriny, M.; de Saint Aubain, N.; Clement, P. M.; Coropciuc, R.; Hauben, E.; Licitra, L. F. | |
| Is PSA useful in the diagnosis and monitoring of parotid adenocarcinomas? | 1-gen-2005 | Bergamini, C.; Barisella, M.; Locati, L. D.; Bossi, P.; Potepan, P.; Rinaldi, G.; Licitra, L. | |
| Lung metastasectomy in adenoid cystic carcinoma (ACC) of salivary gland | 1-gen-2005 | Locati, L. D.; Guzzo, M.; Bossi, P.; Massone, P. P. B.; Conti, B.; Fumagalli, E.; Bareggi, C.; Cantu, G.; Licitra, L. | |
| A complete remission with androgen-deprivation therapy in a recurrent androgen recptor-expressing adenocarcinoma of the parotid gland [1] | 1-gen-2003 | Locati, L. D.; Quattrone, P.; Bossi, P.; Marchiano, A. V.; Cantu, G.; Licitra, L. | |
| Head and neck tumors other than squamous cell carcinoma | 1-gen-2004 | Licitra, L.; Locati, L. D.; Bossi, P.; Cantu, G. | |
| Circulating pre-treatment Epstein-Barr virus DNA as prognostic factor in locally-advanced nasopharyngeal cancer in a nonendemic area | 1-gen-2017 | Alfieri, S.; Iacovelli, N. A.; Marceglia, S.; Lasorsa, I.; Resteghini, C.; Taverna, F.; Mazzocchi, A.; Orlandi, E.; Guzzo, M.; Bianchi, R.; Fanti, D.; Pala, L.; Racca, S.; Dvir, R.; Quattrone, P.; Gloghini, A.; Volpi, C. C.; Granata, R.; Bergamini, C.; Locati, L.; Licitra, L.; Bossi, P. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista48026
Data di pubblicazione
- In corso di stampa78
- 2020 - 202714248
- 2010 - 201916686
- 2000 - 200910045
- 1990 - 19994739
- 1980 - 19891875
- 1970 - 1979350
- 1960 - 19694
- 1959 - 19591
Editore
- Elsevier BV:PO Box 211, 1000 AE A...269
- Lippincott, Williams & Wilkins:53...147
- Elsevier Science Limited:Oxford F...132
- Springer Verlag Germany:Tiergarte...112
- Giuffre Editore Spa:via Busto Ars...107
- American Institute of Physics:2 H...90
- Optical Society of America:2010 M...86
- Academic Press Incorporated:6277 ...78
- Edizioni Minerva Medica:Corso Bra...75
- Blackwell Science Limited:PO Box ...73
Rivista
- PHYSICS LETTERS. SECTION B377
- EUROPEAN JOURNAL OF HEART FAILURE262
- GIORNALE ITALIANO DI MEDICINA DEL...210
- JOURNAL OF HIGH ENERGY PHYSICS210
- PHYSICAL REVIEW LETTERS202
- SENSORS AND ACTUATORS. B, CHEMICAL199
- EFSA JOURNAL185
- PLOS ONE176
- JOURNAL OF CLINICAL MEDICINE172
- BLOOD167
Keyword
- Humans2748
- Male1285
- Female1270
- Middle Aged840
- Aged769
- Adult696
- COVID-19535
- Italy426
- Treatment Outcome348
- Nuclear and High Energy Physics339
Lingua
- eng38596
- ita7400
- fre130
- spa119
- enm41
- und29
- ger27
- por16
- chi4
- bul3
Accesso al fulltext
- no fulltext31385
- open7285
- reserved5941
- restricted3344
- partially open51
- embargoed15
- mixed5